Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-28T15:28:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-21T21:38:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now identifies the software as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-14T21:41:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov software revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T21:52:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The record history now shows the page revision as v3.7.0, replacing the previous v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-16T22:20:19.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag v3.6.6. The previous revision v3.6.5 is removed, signaling an update to the page's revision metadata rather than content changes.
    Difference
    0.1%
    Check dated 2026-09-02T19:32:58.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.